| Literature DB >> 26741655 |
Kyung Eun Kim1, Keon-Hee Ko2,3, Rok Won Heo1, Chin-ok Yi1, Hyun Joo Shin1, Jun Young Kim4, Jae-Ho Park5, Sanghae Nam3, Hwajin Kim1, Gu Seob Roh1.
Abstract
Artemisia annua L. (AA) is a well-known source of the antimalarial drug artemisinin. AA also has an antibacterial and antioxidant activity. However, the effect of AA extract on hepatic steatosis induced by obesity is unclear. We investigated whether AA extract prevents obesity-induced insulin resistance and hepatic steatosis in high-fat diet (HFD)-fed mice. Mice were randomly divided into groups that received a normal chow diet or HFD with or without AA for 12 weeks. We found that AA extract reduced insulin resistance and hepatic steatosis in HFD-fed mice. Western blot analysis showed that HFD-induced expression of nuclear sterol regulatory element-binding protein 1 and carbohydrate-responsive element-binding protein in the livers was decreased by AA extract. In particular, dietary administration of AA extract decreased hepatic high-mobility group box 1 and cyclooxygenase-2 expression in HFD-fed mice. AA extract also attenuated HFD-induced collagen deposition and fibrosis-related transforming growth factor-β1 and connective tissue growth factor. These data indicate that dietary AA extract has beneficial effects on hepatic steatosis and inflammation in HFD-fed mice.Entities:
Keywords: Artemisia annua L.; hepatic inflammation; hepatic steatosis; obesity
Mesh:
Substances:
Year: 2016 PMID: 26741655 PMCID: PMC4799707 DOI: 10.1089/jmf.2015.3527
Source DB: PubMed Journal: J Med Food ISSN: 1096-620X Impact factor: 2.786